EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Implementing a Tiered Genetic Testing Strategy for Muscular Dystrophies in Morocco: From Targeted Assays to Exome Sequencing

Yasmina Rahmuni iD, Ilham Ratbi, Jaber Lyahyai, Imane Cherkaoui Jaouad, Ourayna Batta, Aziza Sbiti, Maryem Sahli, Omar Askander, Zineb Rchiad, Abdelaziz Sefiani

Molecular Genetics & Genomic Medicine · 2026-03 · 14 (3)

DOI: 10.1002/mgg3.70192 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Genetics & Genomic Medicine, online erschienen am 25.02.2026. Verfasst von Yasmina Rahmuni und 9 weiteren Autor:innen. Beteiligte Einrichtung: Research Team in Genomics and Molecular Epidemiology of Genetic Diseases, GENOPATH Center, Faculty of Medicine and Pharmacy, University Mohammed V of…. Hauptthemen laut MEDLINE: Genetic Testing, Exome Sequencing, Muscular Dystrophies, Limb-Girdle, Muscular Dystrophies. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Muscular dystrophies (MDs) are a heterogeneous group of inherited neuromuscular disorders. In Morocco, where consanguinity is common, recurrent variants have been reported; however, the overall molecular landscape remains underexplored.

Methods

We analyzed 716 patients referred over 32 years for suspected limb‐girdle muscular dystrophy (LGMD) or dystrophinopathy using a stepwise approach. Multiplex PCR (MPCR) for DMD deletions and targeted Sanger sequencing of the SGCG :c.525delT variant were performed as first‐line tests. Unsolved patients underwent next‐generation sequencing (NGS), either via a customized gene panel or whole‐exome sequencing (WES).

Results

Multiplex PCR for DMD deletions and targeted Sanger sequencing of the SGCG :c.525delT variant resolved nearly half of cases, demonstrating the efficiency of these cost‐effective first‐line tests. Unsolved patients underwent next‐generation sequencing (NGS), via a customized gene panel or whole‐exome sequencing (WES), though resource limitations prevented full coverage. Among tested cases, SGCA , CAPN3 , and FKRP were the most frequently mutated genes after DMD and SGCG , with several novel or recurrent variants suggesting population‐specific alleles.

Conclusions

These results highlight the genetic heterogeneity of MDs in Morocco and the value of combining targeted and broad genomic approaches, while underscoring the need to extend NGS to fully characterize unresolved patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Genetic TestingExome SequencingMuscular Dystrophies, Limb-GirdleMuscular DystrophiesHumansMoroccoFemaleMaleHigh-Throughput Nucleotide SequencingChildSarcoglycansAdultCalpainAdolescentChild, PreschoolMuscle ProteinsDystrophinYoung Adult

Stichwörter der Autor:innen

LGMDNGSWEScustomized paneldystrophinopathymuscular dystrophy

Substanzen

SarcoglycansCalpainCAPN3 protein, humanMuscle ProteinsSGCA protein, humanDystrophinDMD protein, human

Autor:innen und Institutionen

  • Research Team in Genomics and Molecular Epidemiology of Genetic Diseases, GENOPATH Center, Faculty of Medicine and Pharmacy, University Mohammed V of Rabat, Rabat, Morocco.
  • Department of Medical Genetics, National Institute of Health, Rabat, Morocco.
  • Unity of Medical Genetics, Children's Hospital, Ibn Sina University Hospital Center, Faculty of Medicine and Pharmacy, Mohammed V University of Rabat, Rabat, Morocco.
  • Mohammed VI Center for Research and Innovation (CM6RI), Rabat, Morocco.
  • Genomics Platform, UM6P Corelab, University Mohammed VI Polytechnic, Benguerir, Morocco.

ORCID-Profile: Yasmina Rahmuni

Zitieren

APA

Rahmuni, Y., Ratbi, I., Lyahyai, J., Jaouad, I. C., Batta, O., Sbiti, A., Sahli, M., Askander, O., Rchiad, Z., & Sefiani, A. (2026). Implementing a Tiered Genetic Testing Strategy for Muscular Dystrophies in Morocco: From Targeted Assays to Exome Sequencing. Molecular Genetics & Genomic Medicine, 14(3). https://doi.org/10.1002/mgg3.70192

Vancouver

Rahmuni Y, Ratbi I, Lyahyai J, Jaouad IC, Batta O, Sbiti A, et al. Implementing a Tiered Genetic Testing Strategy for Muscular Dystrophies in Morocco: From Targeted Assays to Exome Sequencing. Molecular Genetics & Genomic Medicine. 2026;14(3). doi:10.1002/mgg3.70192

BibTeX
@article{Rahmuni2026,
  author = {Rahmuni, Yasmina and Ratbi, Ilham and Lyahyai, Jaber and Jaouad, Imane Cherkaoui and Batta, Ourayna and Sbiti, Aziza and Sahli, Maryem and Askander, Omar and Rchiad, Zineb and Sefiani, Abdelaziz},
  title = {Implementing a Tiered Genetic Testing Strategy for Muscular Dystrophies in Morocco: From Targeted Assays to Exome Sequencing},
  journal = {Molecular Genetics & Genomic Medicine},
  year = {2026},
  volume = {14},
  number = {3},
  doi = {10.1002/mgg3.70192}
}
Kostenlos starten →